Federation of BiH sold its 19.2 percent stake in generic drugmaker Bosnalijek on Thursday for a higher than expected 23.4 million Bosnian marka ($13.4 million) after several previous attempts to sell failed.
The stake was bought by a single buyer, although the Sarajevo Stock Exchange (SASE), which organised the auction, could not say who the winning bidder was.
A broker said there were two bidders for the stake.
The Federation government cut the price of Bosnalijek shares to 14.74 marka per share from 15.51 marka in July, when its offer failed to attract bids.
But due to the strong demand on Thursday, it sold the shares at the original price of 15.51 marka.
A Luxembourg-based company, Haden S.A., is the biggest shareholder in Bosnalijek, owning nearly 30 percent of shares. The rest are held by investment funds and small shareholders.
